An appraisal of acitretin therapy in children with inherited disorders of keratinization

British Journal of Dermatology

Volumn 134, Issue 6, 1996, Pages 1023-1029

  Lacour, M ^a   Mehta Nikhar, B ^a   Atherton, D J ^a   Harper, J I ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; ETRETINATE; TRIACYLGLYCEROL;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSKERATOSIS; FEMALE; HUMAN; LAMELLAR ICHTHYOSIS; LIP DISEASE; MALE; PRIORITY JOURNAL; PRURITUS;

EID: 0029955227     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07936.x     Document Type: Article

References (31)

1. Geiger J-M, Saurat J-H. Acitretin and etretinate. How and when they should be used. Dermatol Clin 1993;11:117-29.
2. Larsen FG. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis. Acta Derm Venereol (Stockh) 1994; 74 (Suppl. 190).
3. Gollnick H, Bauer R, Brindley C et al. Acitretin versus etretinate in psoriasis. J Am Acad Dermatol 1988; 19: 458-69.
4. Kragballe K, Jansen CT, Geiger J-M et al. A double-Mind comparison of acitretin and etretinate in the treatment of severe psoriasis. Acta Derm Venereol (Stockh) 1989; 69: 35-40.
5. Ledo A, Martin M, Geiger J-M, Marron JM. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate. Pharmacol Ther 1988; 27: 656-60.
6. Meffert H, Sönnichsen N. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate. Acta Derm Venereol (Stockh) 1989; 146: 176-7.
7. de Prost Y, Bodemer C, Teillac D, Garabedian M. Acitretin in children. In: Retinoids: 10 Years On (Saurat J-H, ed). Basel: Karger, 199; 228-32.
8. Blanchet-Bardon C, Nazzaro V, Rognin C et al. Acitretin in the treatment of severe disorders of keratinization. J Am Acad Dermatol 1991; 24: 9982-6.
9. Judge MR, Misch K, Wright K, Harper JI. Palmoplantar and periorificial keratoderma with corneal epithelial dysplasia: a new syndrome. Br J Dermatol 1991; 125: 186-8.
10. Kalter DC, Atherton DJ, Clayton PT. X-linked dominant Conradi-Hünermann syndrome presenting as congenital erythroderma. J Am Acad Dermatol 1989; 21: 248-56.
11. Hartschuh W, Hausser I, Petzoldt D. Erfolgreiche Retinoitherapie des Nethertons-Syndroms. Haut 1989; 40: 430-3.
12. Traupe H, Happle R. Etretinate therapy in children with severe keratinization defects. Eur J Pediatr 1985; 143: 166-9.
13. Judge MR, Morgan G, Harper JI. A clinical and immunological study of Netherton's syndrome. Br J Dermatol 1994; 131: 615-21.
14. Steijlen PM, van Dooren-Greebe RJ, van de Kerkhof PCM. Acitretin in the treatment of lamellar ichthyosis. Br J Dermatol 1994; 130: 211-14.
15. Ruiz-Maldonado R, Tamayo L. Retinoids in disorders of keratinization: their use in children. Dermatologica 1987; 175 (Suppl. 1): 125-32.
16. Geiger J-M, Baudin M, Saurat J-H, Teratogenic risk with etretinate and acitretin treatment. Dermatology 1994; 189: 109-16.
17. Halkier-Sørensen L, Laurberg G, Andersen J. Bone changes in children on long-term treatment with etretinate. J Am Acad Dermatol 1987; 16: 999-1006.
18. Huber M, Rettler I, Bernasconi K et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995; 267: 525-8.
19. Russell LJ, DiGiovanna JJ, Rogers GR et al. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nature Genet 1995; 9: 279-83.
20. Coulombe PA. The cellular and molecular biology of keratins: beginning a new era. Curr Opin Cell Biol 1993; 5: 17-29.
21. Burge SM. Darier's disease and other dyskeratoses. Response to retinoids. Pharmacol Ther 1989; 40: 75-90.
22. Christophersen J, Geiger J-M, Danneskiold-Samsoe P et al. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease. Acta Derm Venereol (Stockh) 1992; 72: 150-2.
23. Saurat J-H. Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27: S23-S28.
24. Paige DG, Judge MR, Shaw DG et al. Bone changes and their significance in children with ichthyosis on long-term etretinate therapy. Br J Dermatol 1992; 127: 387-91.
25. DiGiovanna JJ, Peck GL. Oral synthetic retinoid treatment in children. Pediatr Dermatol 1983; 1: 77-88.
26. Glover MT, Peters AM, Atherton DJ. Surveillance for skeletal toxicity of children treated with etretinate. Br J Dermatol 1987 ; 116: 609-14.
27. Prendeville J, Bingham EA, Burrows D. Premature epiphyseal closure - a complication of etretinate therapy in children. J Am Acad Dermatol 1986; 17: 1259-69.
28. Mørk N-J, Kolbenstveldt A, Austad J. Efficacy and skeletal side effects of two years' acitretin treatment. Acta Derm Venereol (Stockh) 1992; 72: 445-8.
29. Halkier-Sørensen L, Andresen J. A retrospective study of bone changes in adults treated with etretinate. J Am Acad Dermatol 1989; 20:83-7.
30. DiGiovanna JJ, Helfgott RK, Gerber LH, Peck GL. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. N Engl J Med 1986; 315: 1177-82.
31. van Dooren-Greebe RJ, van de Kerkhof PCM. Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris. J Am Acad Dermatol 1995; 32: 322-5.